Navigation Links
Leading Neurologist Opens Missouri Baptist Medical Center's First MS Center
Date:8/22/2008

ST. LOUIS, Aug. 22 /PRNewswire/ -- Barry Singer, M.D., leading neurologist and adjunct assistant professor of clinical neurology at Washington University School of Medicine, will open The MS Center for Innovations in Care on the campus of Missouri Baptist Medical Center on August 18th.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080822/AQF023)

Multiple Sclerosis (or MS) is a chronic, often disabling disease that attacks the central nervous system, which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild, such as numbness in the limbs, or severe, such as paralysis or loss of vision. The progress, severity, and specific symptoms of MS are unpredictable and vary from one person to another.

"Dr. Singer's new MS Center will bring innovations in treating this disease as well as cutting-edge care for MS patients in region," said Joan Magruder, president, Missouri Baptist Medical Center. "As a principal investigator, Dr. Singer has been involved in major clinical trials for multiple sclerosis, including potential new treatments. He is a leader in bringing advancements in research and early treatment to individuals with MS, and we are thrilled to have him coming on-staff."

Concurrently with his move to Missouri Baptist, Dr. Singer has launched a new website, http://www.mslivingwell.org, where he offers information to empower patients so they can maximize their potential to live well with multiple sclerosis. "Learning more about MS, including treatment options, allows people living with MS to make better decisions that can affect them now and in the future," said Dr. Singer.

Dr. Singer, a native of St. Louis, is board-certified in neurology. He earned his undergraduate degree from Duke University and his medical degree from Columbia University College of Physicians and Surgeons. He completed his residency training in neurology at New York Hospital-Cornell University. In addition, Dr. Singer completed a neuroimmunology fellowship focusing on clinical and laboratory research in multiple sclerosis at the National Institutes of Health. He is an active member of the American Academy of Neurology and serves as a member of the clinical advisory committee of the Gateway Chapter of the National Multiple Sclerosis Society.

In January 2008, he received the Pathlighter Award from the National Multiple Sclerosis Society. In March 2008, Dr. Singer was a recipient of a Congressional Proclamation from Congressman Russ Carnahan, who co-chairs the Congressional MS Caucus, for accomplishments in research in MS.

The MS Center for Innovations in Care will be located in Physicians' Office Building B, Suite 207, Missouri Baptist Medical Center, 3015 North Ballas Rd., St. Louis, Mo, 63131.


'/>"/>
SOURCE The MS Center for Innovations in Care at the MissouriBaptist
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... a new partnership with the Rhode Island Consortium for Autism Research and Treatment ... opportunity for children with autism spectrum disorder (ASD) to see films in an ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When ... new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. ... healthcare systems recently invested $51 million to purchase and renovate the 185,000 square-foot ...
(Date:2/22/2017)... Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... detox treatment to the thousands of individuals who have recently fallen victim to America’s ... hospital in Orange County, California, where they are free from the shame, stigma, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017   SeraCare Life ... global in vitro diagnostics manufacturers and clinical laboratories, ... "Catalyzing Implementation of NGS-Based Tests" to be hosted ... 2017 at 11am Eastern Standard Time (US). ... highlight the need for improved performance and global ...
(Date:2/23/2017)... -- ML Capital Group, Inc. (USOTC: MLCG) today announced ... , a Colorado -based cannabis tourism company. ... (USOTC: PURA) to enter Colorado,s $19 billion ... Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
Breaking Medicine Technology: